When the MDGI‐silenced cells were injected intracranially into immunocompromised mice, no tumour formation was observed, while the control shRNA (Scr)‐infected cells formed invasive tumours (Figs 3E and F, and Appendix Fig S2A–C). This evidence concerns the gene FABP3 and neoplasm.